Home › Compare › IVIXF vs NNN

IVIXF vs NNN: Dividend Comparison 2026

IVIXF yields 5420.05% · NNN yields 5.66%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IVIXF wins by $136326195118802.20M in total portfolio value
10 years
IVIXF
IVIXF
● Live price
5420.05%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$136326195118802.23M
Annual income
$131,551,666,493,773,860,000.00
Full IVIXF calculator →
NNN
NNN REIT Inc.
● Live price
5.66%
Share price
$42.03
Annual div
$2.38
5Y div CAGR
8.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.5K
Annual income
$2,622.67
Full NNN calculator →

Portfolio growth — IVIXF vs NNN

📍 IVIXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIVIXFNNN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IVIXF + NNN cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
IVIXF pays
NNN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IVIXF
Annual income on $10K today (after 15% tax)
$460,704.61/yr
After 10yr DRIP, annual income (after tax)
$111,818,916,519,707,770,000.00/yr
NNN
Annual income on $10K today (after 15% tax)
$481.32/yr
After 10yr DRIP, annual income (after tax)
$2,229.27/yr
At 15% tax rate, IVIXF beats the other by $111,818,916,519,707,770,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IVIXF + NNN for your $10,000?

IVIXF: 50%NNN: 50%
100% NNN50/50100% IVIXF
Portfolio after 10yr
$68163097559401.13M
Annual income
$65,775,833,246,886,930,000.00/yr
Blended yield
96.50%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

IVIXF
No analyst data
Altman Z
-30.2
Piotroski
1/9
NNN
Analyst Ratings
10
Buy
15
Hold
4
Sell
Consensus: Hold
Price Target
$44.93
+6.9% upside vs current
Range: $43.00 — $48.50
Altman Z
1.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IVIXF buys
0
NNN buys
0
No recent congressional trades found for IVIXF or NNN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIVIXFNNN
Forward yield5420.05% ✓5.66%
Annual dividend / share$2.00$2.38 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%8.6% ✓
Portfolio after 10y$136326195118802.23M ✓$25.5K
Annual income after 10y$131,551,666,493,773,860,000.00 ✓$2,622.67
Total dividends collected$136003983287005.17M ✓$13.7K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: IVIXF vs NNN ($10,000, DRIP)

YearIVIXF PortfolioIVIXF Income/yrNNN PortfolioNNN Income/yrGap
1← crossover$552,705$542,005.42$10,735$614.96+$542.0K → IVIXF
2$28,588,529$27,997,133.96$11,572$708.43+$28.58M → IVIXF
3$1,383,995,048$1,353,405,322.61$12,531$819.53+$1383.98M → IVIXF
4$62,714,057,337$61,233,182,635.19$13,633$952.29+$62714.04M → IVIXF
5$2,660,288,543,813$2,593,184,502,462.66$14,909$1,111.84+$2660288.53M → IVIXF
6$105,651,330,702,723$102,804,821,960,842.73$16,392$1,304.77+$105651330.69M → IVIXF
7$3,928,761,972,612,137$3,815,715,048,760,222.50$18,129$1,539.52+$3928761972.59M → IVIXF
8$136,812,745,737,264,320$132,608,970,426,569,340.00$20,173$1,827.08+$136812745737.24M → IVIXF
9$4,462,176,285,073,260,500$4,315,786,647,134,387,700.00$22,597$2,181.81+$4462176285073.24M → IVIXF
10$136,326,195,118,802,240,000$131,551,666,493,773,860,000.00$25,491$2,622.67+$136326195118802.20M → IVIXF

IVIXF vs NNN: Complete Analysis 2026

IVIXF — Stock

Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company was incorporated in 2000 and is headquartered in Melbourne, Australia.

Full IVIXF Calculator →

NNN — REIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →
📬

Get this IVIXF vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IVIXF vs SCHDIVIXF vs JEPIIVIXF vs OIVIXF vs KOIVIXF vs MAINIVIXF vs ADCIVIXF vs EPRTIVIXF vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.